Zai Lab Limited
ZLAB
$18.61
-$0.49-2.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -21.93% | 9.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -21.93% | 9.91% | |||
| Cost of Revenue | -16.16% | 30.75% | |||
| Gross Profit | -218.77% | -82.93% | |||
| SG&A Expenses | -10.91% | 4.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.22% | 19.46% | |||
| Operating Income | 0.03% | -42.16% | |||
| Income Before Tax | 7.05% | -48.31% | |||
| Income Tax Expenses | 149.20% | -- | |||
| Earnings from Continuing Operations | -1.20% | -40.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.20% | -40.17% | |||
| EBIT | 0.03% | -42.16% | |||
| EBITDA | 0.07% | -45.79% | |||
| EPS Basic | -1.08% | -39.69% | |||
| Normalized Basic EPS | 7.17% | -47.75% | |||
| EPS Diluted | -1.08% | -39.69% | |||
| Normalized Diluted EPS | 7.17% | -47.75% | |||
| Average Basic Shares Outstanding | 0.12% | 0.36% | |||
| Average Diluted Shares Outstanding | 0.12% | 0.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||